StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research note published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $10.00 price target on shares of Pulmatrix in a report on Tuesday, February 7th. Pulmatrix […]